申请人:Eli Lilly and Company
公开号:US05436229A1
公开(公告)日:1995-07-25
This invention relates to bisulfite adducts of L-Arginine aldehyde derivatives, pharmaceutical formulations containing those adducts and methods of their use as thrombin inhibitors, coagulation inhibitors and thromboembolic disorder agents.
这项发明涉及L-精氨酸醛衍生物的亚硫酸氢盐加合物,含有这些加合物的药物配方以及其作为凝血酶抑制剂、凝血抑制剂和血栓栓塞性疾病药物的使用方法。